NCT05620693View on ClinicalTrials.gov

Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2028

Conditions

Advanced Soft-tissue Sarcoma

Interventions

BIOLOGICAL

NY-ESO-1 TCR-T

NY-ESO-1 TCR-T treatment

Trial Locations (1)

518000

RECRUITING

Li Yu, Shenzhen

All Listed Sponsors

lead

Shenzhen University General Hospital

OTHER